Nkarta Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
September 05, 2019
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$114,000,000

Company Info
Company Description
Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
Market
Cancer Therapy
Location
South San Francisco, California, USA
Coinvestors
Amgen Business Development, Deerfield Management Company, L.P., Life Sciences Partners, Logos Capital, NEA Ventures, Novo Holdings, RA Capital, Samsara BioCapital, SR One

Links